DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172939

Estimation of serum 25 hydroxy vitamin D level and its correlation with metabolic and endocrine dysregulation in women with PCOS

Vandana Solanki, Amrita Chaurasia, Shalini Singh, Shikha Sachan, Kachnar Varma, Rekha Devi

Abstract


Background: Polycystic ovarian syndrome is the most common hormonal disturbance in the reproductive age women, with prevalence of 5-10%. Vitamin D deficiency is common in women with or without PCOS. The aim of this study was to assess association of serum vitamin D level with metabolic and endocrine dysregulation in women with PCOS.

Methods: This cross-sectional study was done over a period of one year. 100 women of age group 20-40 years were divided in group A 30 (BMI >30 mg/m2) with PCOS, group B 20 (BMI <25 mg/m2) with PCOS, group C 50 controls and were investigated for serum FSH, LH, LH/FSH ratio, S. total testosterone, S. postprandial insulin level, glucose insulin ratio, 25 hydroxy vitamin D level.

Results: LH/FSH ratio >2 (33.33% in obese and 50% in non-obese), serum total testosterone level >0.8ng/ml (80% in obese and 75% in non-obese) (p value was significant between study group as well as between study and control group). Serum fasting, postprandial blood glucose, postprandial serum insulin level was elevated in obese than non-obese PCOS. 25 (OH) vitamin D deficiency <20 ng/ml (56.675% in obese and 45% in non-obese). So, vitamin D deficiency was more common in obese PCOS.

Conclusions: PCOS is more common in age group of 20-40 years. There is more Insulin resistance in obese PCOS as compared to non-obese PCOS. Vitamin D deficiency is comparatively more common in obese PCOS population than in non-obese PCOS.

 


Keywords


Non-obese PCOS, Obese PCOS, Vitamin D

Full Text:

PDF

References


Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG. Cardio metabolic risk in polycystic ovarian syndrome a comparison of different approaches to defining the metabolic syndrome. Hum Reprod. 2008;23:2532-8.

Barber TM, Frank S. The link between polycystic ovarian syndrome and both type 1 and 2 diabetes mellitus. What we know today? Women’s health. 2012;8(2):147-54.

Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG .2006;113:1148-59.

Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S et al. Low serum 25-hydroxy vitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovarian syndrome. Exp Clin Endocriol Diabetes. 2006;114(10):577-83.

Barberi RL, Makris A, Randall RW, Daniels G, Kistrer RW, Ryan KJ. Insulin stimulates androgen accumulation in ovarian stroma obtained from women with hyperandrogenism. J Endocrinal Metab. 1986;62(5):904-10

Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22:82-92.

Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. AM J Clin Nutr. 2004;79(5):820-5.

Balen AH, Conway GS, Kaltsas G, Techatraisak K, Manning PJ, West C et al. Polycystic ovarian syndrome: The spectrum of the disorder in 1741 patients. Human Reprod. 1995;10:2107-11.

Najem FI, Eehdawi, Swalem AM. Clinical and biochemical characteristic of polycystic ovary syndrome in Benghazi – Libya; A Retrospective study. Libyan J Med. 2008;3(2):71-74.

Mahmood MI, Habeeb F, Kasim K. Reproductive and biochemical change in obese non-obese polycystic ovary syndrome women. Alaxandria J Med. 2015;51(1):5-9.

Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B. Serum 25 hydroxy vitamin D concentration in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009;280(4):559.

Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber, Obermayer-Pietsch B. Association of hypovitaminosis D with metabolic disturbances in polycystic ovarian syndrome. Eur J Endocrinol. 2009;161(4):575-82.